SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000769993-19-000144
Filing Date
2019-02-07
Accepted
2019-02-07 17:10:59
Documents
1
Group Members
GOLDMAN SACHS & CO. LLC

Document Format Files

Seq Description Document Type Size
1 4Q18 13G PROQR THERAPUETICS 13G_PROQR.txt SC 13G 21782
  Complete submission text file 0000769993-19-000144.txt   23483
Mailing Address 200 WEST STREET NEW YORK NY 10282
Business Address 200 WEST STREET NEW YORK NY 10282 2129021000
GOLDMAN SACHS GROUP INC (Filed by) CIK: 0000886982 (see all company filings)

IRS No.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address DARWINWEG 24 LEIDEN P7 2333CR
Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000
ProQR Therapeutics N.V. (Subject) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88671 | Film No.: 19575973
SIC: 2834 Pharmaceutical Preparations